Aayerah Pharmaceuticals Private Limited - Due diligence report
A 360° intelligence report on Aayerah Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gr…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Aayerah Pharmaceuticals Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsAayerah Pharmaceuticals Private Limited is assessed as Moderate with a Trust Score of 68/100. Aayerah Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 22 Nov 2026 from the latest processed filings. Aayerah Pharmaceuticals Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 0 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they areCharges position: 1 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).
| Lender | Charges | Amount |
|---|---|---|
| Others | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| HALIMA SADEEYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AKBAR KHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 75 · Distress 60Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 1 open charge(s) already registered.
- Compliance record supports lending.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 7 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| The Last Centre | U85100DL2012NPL241158 | Delhi, Delhi, India |
| Sugna Mohan Kaswa Memorial And Construction Private Limited | U85110RJ2019PTC063739 | Jhunjhunun, Rajasthan, India |
| Vital Digital Healthcare Private Limited | U85100MH2021PTC365470 | Mumbai, Maharashtra, India |
| Osler Clinic Private Limited | U85190JH2021PTC016170 | Ranchi, Jharkhand, India |
| Medicuality Health Care Services (Opc) Private Limited | U85100KA2021OPC144455 | Bangarpet, Karnataka, India |
| Medicure Diagnostic And Polyclinic Private Limited | U85100WB2020PTC241407 | Kolkata, West Bengal, India |
| Uchit Diagnostic Private Limited | U85110CH2020PTC043376 | Chandigarh, Chandigarh, India |
| Rose Dialysis Center (Opc) Private Limited | U85100DL2020OPC361199 | Delhi, Delhi, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Aayerah Pharmaceuticals Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Aayerah Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Aayerah Pharmaceuticals Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Aayerah Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Aayerah Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Aayerah Pharmaceuticals Private Limited an active company?
Aayerah Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Aayerah Pharmaceuticals Private Limited financially healthy?
Aayerah Pharmaceuticals Private Limited has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Aayerah Pharmaceuticals Private Limited?
Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Aayerah Pharmaceuticals Private Limited?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Aayerah Pharmaceuticals Private Limited have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Aayerah Pharmaceuticals Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Aayerah Pharmaceuticals Private Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.